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Abstract
Background—Increased rates of psychiatric disorder have previously been reported in those
diagnosed with chronic fatigue syndrome (CFS) or myalgic encephalomyelitis (ME), although the
direction of causation in this relationship has not been established. We aimed to test the hypothesis
that individuals with self-reported CFS/ME have increased levels of psychiatric disorder prior to
the onset of their fatigue symptoms.
Method—A total of 5362 participants were prospectively followed with various measures of
personality, psychiatric disorder and fatigue levels collected over the first 43 years of their life.
CFS/ME was identified through self-report during a semi-structured interview at age 53 years.
Results—Thirty-four (1.1%) of the 3035 subjects assessed at age 53 years reported a diagnosis
of CFS/ME. CFS/ME was more common among females, but there was no association between
CFS/ME and either social class, social mobility or educational level. Those with psychiatric illness
between the ages of 15 and 36 years were more likely to report CFS/ME later in life with an odds
ratio (OR, adjusted for sex) of 2.65 [95% confidence interval (CI) 1.26–5.57, p=0.01]. Increased
levels of psychiatric illness, in particular depression and anxiety, were present prior to the
occurrence of fatigue symptoms. There was a dose–response relationship between the severity of
psychiatric symptoms and the likelihood of later CFS/ME. Personality factors were not associated
with a self-reported diagnosis of CFS/ME.
Conclusions—This temporal, dose–response relationship suggests that psychiatric disorders, or
shared risk factors for psychiatric disorders, are likely to have an aetiological role in some cases of
CFS/ME.
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Introduction
Chronic fatigue syndrome (CFS), or myalgic encephalomyelitis (ME), is characterized by
severe persistent or relapsing fatigue, lasting 6 or more consecutive months, that is not
relieved by rest and is accompanied by a number of other somatic and cognitive symptoms
© 2007 Cambridge University Press
*Address for correspondence : Weston Education Centre, 10 Cutcombe Road, London SE5 9RJ, UK. (m.hotopf@iop.kcl.ac.uk) .
Declaration of Interest None.
Europe PMC Funders Group
Author Manuscript
Psychol Med. Author manuscript; available in PMC 2011 October 19.
Published in final edited form as:
Psychol Med. 2008 July ; 38(7): 933–940. doi:10.1017/S0033291707001900.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
(Fukuda et al. 1994). Despite significant research interest, the aetiology of CFS/ME remains
unclear (Afari & Buchwald, 2003; Prins et al. 2006). There has, however, been a consistent
finding of a strong association between CFS/ME and psychiatric disorder found in numerous
case–control and cross-sectional studies (David, 1991). Possible explanations for this
relationship include psychiatric disorders occurring as a consequence of CFS/ME,
psychiatric disorders having a causal role in the aetiology of CFS/ME or misdiagnosis and/
or bias occurring within these studies (Wessely et al. 1998). Differentiating between these
possible explanations has not been possible because of the retrospective or cross-sectional
nature of most previous research. Attempts have been made to investigate the temporal
relationship between CFS/ME and psychiatric symptoms using prospective studies of
fatigue following viral illness; however, the results in such studies have been inconclusive
(Hotopf et al. 1996; White et al. 2001; Petersen et al. 2006). Larger, population-based,
prospective studies examining CFS/ME have been difficult because of the relatively low
prevalence of this outcome. Analysis of prospectively studied birth cohorts has shown that
neither maternal nor childhood psychological disorders were associated with increased risk
of CFS/ME as an adult (Viner & Hotopf, 2004). Similar analysis of adult psychiatric
disorder has not previously been possible.
In this study we used the Medical Research Council National Survey of Health and
Development, a British national birth cohort, to examine prospectively the relationship
between prior psychiatric disorder and self-reported CFS/ME. We aimed to test the
hypothesis that individuals with CFS/ME would have increased levels of psychiatric
disorder prior to the onset of their fatigue symptoms compared to those without CFS/ME.
Method
Sample
The Medical Research Council National Survey of Health and Development was established
in 1946. A random social class-stratified sample of 5362 participants was selected from all
single, legitimate births occurring in England, Wales and Scotland in one week of March
1946. This sample has been prospectively followed with over 20 separate data collections up
to the age of 53 years. The sampling procedure and follow-up have been described in detail
elsewhere (Wadsworth et al. 2006).
Prior psychiatric disorder
Psychiatric disorder was ascertained at several points in the adult life of the sample. At each
follow-up point participants were asked about any contacts with medical practitioners and
about any hospital out-patient or in-patient treatments. If any hospitalizations were reported,
the hospital was contacted and asked to proved details of the admission. This information
was used to construct a summary of any psychiatric disorders that occurred between the ages
of 15 and 32 years. Participants were assessed to either have no mental illness, mild to
moderate mental illness or severe mental illness. Severe mental illness was defined as an
illness with duration of more than one 1 year; or an illness that recurred more than four
times; or that required care from a specialist mental health team.
At age 36 years, participants were visited at home and the 40-item version of the Present
State Examination (PSE; Wing et al. 1974) was administered by a trained nurse interviewer
(Rodgers & Mann, 1986). Psychiatric disorder was defined at a threshold level of ≥5 on the
Index of Definition score (Wing et al. 1978), and the total PSE score was used as a measure
of the severity of psychiatric symptoms (Rodgers & Mann, 1986).
Participants at age 43 years were again visited at home, and interviewed by trained nurses
using the Psychiatric Symptom Frequency scale (PSF; Lindelow et al. 1997). The PSF is an
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18-item scale measuring psychiatric symptoms, particularly of depression and anxiety, over
the past year. A cut-off score of ≥14 was used to define psychiatric disorder (Lindelow et al.
1997).
At ages 36 and 43 years, participants were also asked if they, or either of their parents, had
ever had ‘nervous or emotional trouble or depression’. Participants’ mothers were also asked
about a family history of ‘nerves’ in 1961. At age 13 years, participants completed a Pintner
Personality Inventory (Pintner et al. 1937). This inventory requires the child to read 114
statements and then mark themselves as ‘same’ or ‘different’. It provides a measure of the
child’s personality along the spectrums of neuroticism and introversion/extroversion. At
ages 16 and 26 years, individuals completed the short form of the Maudsley Personality
Inventory (MPI; Eysenck, 1959), which also provides a measure of personality along the
neuroticism and extroversion spectrums.
Sociodemographics
Sociodemographic details including gender, father’s social class (in 1961), participant’s
social class (at age 53 years) and educational level were also obtained. Social class was
derived from the participant’s occupation using the Registrar General’s classification (ONS,
1990) and highest education level achieved was coded using the Burnham classification
(Department of Education and Science, 1972). The direction of any social mobility
throughout the adult life was assessed by examining whether the participant’s social class
had altered between the ages of 15 and 53.
Outcome
At age 53 years, participants were again interviewed at home by trained nurses. During this
semi-structured interview they were asked if they had ever been diagnosed with CFS or ME.
If so, they were asked at what age this problem had begun. Hospital records were reviewed
for all participants who reported suffering from CFS/ME. If these indicated any psychotic or
serious medical disorder that would invalidate the diagnosis of CFS then they were excluded
from further analysis. Individuals with a psychotic mental disorder were also excluded from
the control group. As we aimed to investigate predisposing factors, any participants who
reported CFS/ME symptoms beginning prior to the age of 44 years were excluded from the
analysis of measures collected at the age of 43 years.
To address the issue of early CFS being misdiagnosed as a psychiatric disorder, measures of
participants’ fatigue and fitness levels were taken at ages 15, 31, 36 and 43 years. Reports of
energy levels at age 15 were given by the participants’ teachers while at ages 31, 36 and 43
years they were self-reported.
Statistical analysis
Statistical analysis was performed using Stata software (StataCorp, 2005). Differences
between those with CFS and the remainder of the sample interviewed at age 53 were
initially explored using univariate analysis. Logistic regression analysis was then used to
calculate odds ratios (ORs) corrected for known sociodemographic confounders, such as
gender.
Ethical approval
Ethical approval was given by the London area multi-centre research ethics committee for
the data collection at age 53 years. Cohort members gave informed consent for each
assessment. Ethical approval and consent procedures at earlier ages conformed to
contemporary best practice.
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Results
At age 53 years, 3035 of the original participants were interviewed. After exclusion of those
who had died, moved abroad or had been permanent refusers, this indicated a follow-up rate
of 83%. Analysis reported elsewhere has shown the sample at age 53 years to remain
representative of the national population (Wadsworth et al. 2006).
At age 53, 37 (1.2%) of the sample reported a diagnosis of CFS/ME. Hospital admission
notes for these participants revealed that two had serious medical conditions (meningitis and
chronic active hepatitis) and one had a psychotic disorder (schizophrenia) that required them
to be excluded from further analysis. After these exclusions the lifetime prevalence estimate
for CFS/ME was 1.1% [95% confidence interval (CI) 0.8–1.5]. The age that participants
reported their fatigue symptoms beginning varied between 41 and 53 years. Table 1 shows
the associations between sociodemographic factors and a diagnosis of CFS/ME. Women
were more likely to report a diagnosis of CFS/ME, but neither social class, social mobility
nor educational levels were associated with reported CFS/ME.
The relationships between prior psychiatric disorder and a later diagnosis of CFS/ME are
shown in Table 2. At each psychiatric assessment between ages 15 and 43 years there was a
trend towards increased levels of psychiatric disorder in those who later developed CFS/ME.
Analysis of the PSE subscale scores, obtained at age 36 years, revealed that those who were
later diagnosed with CFS/ME had significantly raised scores in the depressed mood,
generalized anxiety and tension subscales. Seven of the participants who reported CFS/ME
at age 53 years reported their CFS/ME symptoms beginning between the ages of 41 and 43
years, and thus were not included in the analysis involving psychiatric disorder measures at
age 43 years. Their exclusion caused a reduction in the power of these analyses.
At age 15 years there were no significant differences in the levels of energy reported by
participants’ teachers between those who later went on to report a diagnosis CFS/ME and
those who did not. At age 31 years, those who were later to report CFS/ME tended to rate
themselves as having higher levels of fitness (data not shown). Despite this, there was a non-
significant trend towards decreased levels of energy at age 36 years. However, only three of
the participants who later reported a diagnosis of CFS/ME scored highly (above the median)
on the lack of energy PSE subscale, indicating that the vast majority of those who were later
to report CFS/ME were not suffering significant fatigue at age 36 years. Therefore, measures
of psychiatric disorder up to the age of 36 years should be representative of participant’s
pre-fatigued state. By the age of 43 years, those who were later to be diagnosed with CFS/
ME were beginning to report significantly more fatigue than the rest of the sample (data not
shown), suggesting measures of psychiatric disorder taken at this age may not represent true
preceding psychiatric disorder.
Combining the various measures of psychiatric disorder taken up to the age of 36 years
produced an OR (adjusted for sex) for a later diagnoses of CFS/ME in those with any prior
psychiatric disorder of 2.65 (95% CI 1.26–5.57, p=0.01).
To investigate the dose–response relationship between prior psychiatric symptoms and a
later diagnosis of CFS/ME, the total PSE score at age 36 was used to construct ORs
(adjusted for sex) for a diagnosis of CFS/ME at age 53 years. This is demonstrated in Fig. 1.
The relationships between personality measures, parental psychiatric disorder and a later
diagnosis of CFS/ME are shown in Table 3. None of the personality measures used had any
significant impact on the later risk of CFS/ME, but parental psychiatric disorder was more
common among those who later reported CFS/ME.
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Discussion
Principal findings
The finding of an association between psychiatric disorders and CFS/ME is not a new
observation. However, what is unique about this study is that it was able to demonstrate that
those who report a diagnosis of CFS/ME had increased levels of psychiatric disorder, in
particular depression and anxiety, prior to the onset of fatigue symptoms. Those with a
psychiatric disorder in early adult life were around two and a half times more likely to report
a diagnosis of CFS/ME later in life.
Possible causal pathways
Up to the age of 36 years, those who later went on to develop CFS/ME did not have
significant differences in their levels of energy or fatigue, suggesting that misdiagnosis of
early fatigue symptoms as a psychiatric disorder is not a likely explanation for these results.
The temporal, dose–response relationship demonstrated provides some evidence for
psychiatric disorders having a causal role in the aetiology of CFS/ME. Alternatively, our
results may be explained by psychiatric disorders and CFS/ME sharing common
vulnerability factors. A recent study using the Swedish Twin Registry demonstrated that
those who reported higher levels of stress in their early adult life were at increased risk of
developing a chronic fatiguing illness (Kato et al. 2006). It may be that persistent stress, or
the perception of persistent stress, is a shared risk factor for both psychiatric disorder and
CFS/ME. Personality traits are another potential shared risk factor, but our findings suggest
that neither neuroticism, introversion nor extroversion are independent risk factors for CFS/
ME. It may be that elements of personality or attitudes not captured on these scales act as
shared risk factors. Other studies have found an association between CFS/ME and
personality factors such as emotional instability (Kato et al. 2006) and Cluster C personality
traits (Henderson & Tannock, 2004) suggesting this is an area that requires further
investigation. The increased level of family psychiatric illness among individuals who report
CFS/ME is also a novel finding (Endicott, 1999; Torres-Harding et al. 2005). Although this
may point to a common genetic susceptibility, it is perhaps most likely to be explained by
the confounding effect of the strong relationship between family and personal history of
psychiatric disorders.
Strengths and limitations
The strengths of this study include its large size and prospective data collection. The high
follow-up rate and the sample’s generalizability to the British population are also strengths.
Increased loss to follow-up at age 53 years was seen in males, participants from a manual
social class, individuals with lower levels of education, individuals more fatigued at 43 years
and those without a personal or family history of psychiatric illness in early life, although
this did not affect the overall representativeness of the sample (Wadsworth et al. 2006).
Although the use of self-reported CFS/ME is the main limitation of this study, it may also
provide some benefits. Fatigue is a subjective experience that is difficult to define and
therefore difficult to measure (Dittner et al. 2004). At present, there is no accepted
standardized interview for diagnosing CFS/ME in the community, with self-reported levels
of fatigue remaining at the core of the diagnostic criteria (Fukuda et al. 1994). Any attempt
to use more structured diagnostic interviews may fail to capture the phenomena of patients
who complain of fatigue in a clinical setting. In examining those who report a diagnosis of
CFS/ME, we have studied both those who have been given a diagnosis of CFS/ME by the
medical profession and those who have self-diagnosed. We feel this method is likely to have
a high degree of clinical and face validity. Clinical experience suggests that it is uncommon
for a patient to complain of CFS or ME and to not have sufficiently severe symptoms to
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warrant the diagnosis. Despite this, the use of self-reported diagnosis may have caused an
under-ascertainment of cases as some individuals who would meet the criteria for CFS/ME
may not report this as a diagnosis. Provided this misclassification was random, the effect of
this will have been an underestimate of the strength of the associations we report. These
assumptions are supported by our prevalence estimate being lower than previous estimates
of broadly defined chronic fatigue states (Steele et al. 1998), while being higher than that
reported in studies using stricter diagnostic criteria (Jason et al. 1999; Reyes et al. 2003).
The use of self-reported diagnosis is also supported by post-hoc analysis showing that the
association between prior psychiatric disorder and CFS/ME remained, and was in fact
slightly stronger, when patients who had not received their diagnosis of CFS/ME from a
doctor were excluded. The OR (adjusted for sex) of individuals with physician-diagnosed
CFS/ME having prior psychiatric disorder was 3.78 (95% CI 1.38–10.28, p=0.009).
While the number of individuals who reported a diagnosis of CFS/ME was in line with
previous prevalence estimates, the fact that CFS/ME is a relatively rare outcome reduced the
power of this study. This will have increased the chance of type 2 errors, although the fact
we were able to find a series of relatively strong associations suggests that this was not a
major problem. Another potential limitation of this study is that our findings are restricted to
those who reported CFS/ME at a relatively older age. Although participants were asked
about their energy levels at earlier assessments, they were only asked about a diagnosis of
CFS/ME at the age of 53 years. As a result our study only examined individuals with CFS/
ME diagnosed at an older age, with symptoms in our sample beginning between the ages of
41 and 53 years. While some community-based studies have found the prevalence of CFS/
ME to peak between ages 40 and 59 years (Reyes et al. 2003), it remains uncertain if this
sample and conclusions based upon it are representative of those who complain of CFS/ME
at a younger age.
Conclusions
Those who report a diagnosis of CFS/ME have increased levels of psychiatric disorder prior
to the onset of their fatigue symptoms. When present, this psychiatric disorder typically
appears to be depression or anxiety. While further studies are needed to investigate possible
shared vulnerability factors, including personality traits, attitudes and stress, it seems likely
that psychiatric disorders, or risk factors for these disorders, have an aetiological role in
some cases of CFS/ME. An increased understanding regarding the roles of these factors in
the aetiology of CFS/ME will help to provide guidance on the prevention and treatment of
this debilitating and stigmatized condition.
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Fig. 1.
Total Present State Examination (PSE) score at age 36 and odds ratios (adjusted for gender)
for a later diagnosis of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME). p
value for trend=0.001.
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